UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents

FEBS letters, 2002-02, Vol.512 (1), p.59-66

2002

Volltextzugriff (PDF)

Erythromycin block of the HERG K + channel: Accessibility to F656 and Y652

Biochemical and biophysical research communications, 2006-03, Vol.341 (2), p.500-506

2006

Volltextzugriff (PDF)

Time course and voltage dependence of expressed HERG current compared with native "rapid" delayed rectifier K current during the cardiac ventricular action potential

Pflügers Archiv, 1998-11, Vol.436 (6), p.843-853

1998

Volltextzugriff (PDF)

Acquired QT interval prolongation and HERG: implications for drug discovery and development

European journal of pharmacology, 2004-10, Vol.500 (1), p.129-142

2004

Volltextzugriff (PDF)

Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652

British journal of pharmacology, 2003-07, Vol.139 (5), p.887-898

2003

Volltextzugriff (PDF)

Psychotropic drugs, HERG, and the heart

The Lancet (British edition), 2000-07, Vol.356 (9227), p.428-428

2000

Volltextzugriff (PDF)

Psychotropic drugs, cardiac arrhythmia, and sudden death

Journal of clinical psychopharmacology, 2003-02, Vol.23 (1), p.58-77

2003

Volltextzugriff (PDF)

The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C

Biochemical and biophysical research communications, 2005-08, Vol.334 (2), p.441

2005

Volltextzugriff (PDF)

Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin

British journal of pharmacology, 2006-04, Vol.147 (8), p.905-916

2006

Volltextzugriff (PDF)

Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine

British journal of pharmacology, 2002-07, Vol.136 (5), p.717-729

2002

Volltextzugriff (PDF)

The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping

Molecular pharmacology, 2004-11, Vol.66 (5), p.1201-1212

2004

Volltextzugriff (PDF)

High affinity HERG K + channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656

Biochemical and biophysical research communications, 2004-12, Vol.325 (3), p.883-891

2004

Volltextzugriff (PDF)

Familial And Acquired Long QT Syndrome And The Cardiac Rapid Delayed Rectifier Potassium Current

Clinical and experimental pharmacology & physiology, 2000-10, Vol.27 (10), p.753-766

2000

Volltextzugriff (PDF)

Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder

Biological psychiatry (1969), 2004-10, Vol.56 (7), p.503-509

2004

Volltextzugriff (PDF)

Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline

British journal of pharmacology, 1999-09, Vol.128 (2), p.479-485

1999

Volltextzugriff (PDF)

Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K + channel

Journal of molecular and cellular cardiology, 2006, Vol.40 (1), p.107-118

2006

Volltextzugriff (PDF)

Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm-1 scorpion toxin

FEBS letters, 2003-07, Vol.547 (1), p.20-26

2003

Volltextzugriff (PDF)

Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K + channels expressed in mammalian cell lines and Xenopus oocytes

Journal of pharmacological and toxicological methods, 2002-09, Vol.48 (2), p.65-80

2002

Volltextzugriff (PDF)

Inhibition of the HERG K + channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656

FEBS letters, 2006-04, Vol.580 (8), p.1999-2005

2006

Volltextzugriff (PDF)

Lidoflazine is a high affinity blocker of the HERG K +channel

Journal of molecular and cellular cardiology, 2004-05, Vol.36 (5), p.701-705

2004

Volltextzugriff (PDF)

Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine

The Journal of physiology, 2003-06, Vol.549 (3), p.667-672

2003

Volltextzugriff (PDF)

Inhibition of HERG Potassium Channel Current by the Class 1a Antiarrhythmic Agent Disopyramide

Biochemical and biophysical research communications, 2001-02, Vol.280 (5), p.1243-1250

2001

Volltextzugriff (PDF)

Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene—without QT interval prolongation

Biochemical and biophysical research communications, 2004-05, Vol.318 (2), p.556-561

2004

Volltextzugriff (PDF)

Characterisation of recombinant HERG K + channel blockade by the Class Ia antiarrhythmic drug procainamide

Biochemical and biophysical research communications, 2003-06, Vol.306 (2), p.388-393

2003

Volltextzugriff (PDF)

High affinity HERG K super(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656

Biochemical and biophysical research communications, 2004-12, Vol.325 (3), p.883-891

2004

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents

Erythromycin block of the HERG K + channel: Accessibility to F656 and Y652

Time course and voltage dependence of expressed HERG current compared with native "rapid" delayed rectifier K current during the cardiac ventricular action potential

Acquired QT interval prolongation and HERG: implications for drug discovery and development

Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652

Psychotropic drugs, HERG, and the heart

Psychotropic drugs, cardiac arrhythmia, and sudden death

The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C

Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin

Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine

The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping

High affinity HERG K + channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656

Familial And Acquired Long QT Syndrome And The Cardiac Rapid Delayed Rectifier Potassium Current

Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder

Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline

Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K + channel

Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm-1 scorpion toxin

Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K + channels expressed in mammalian cell lines and Xenopus oocytes

Inhibition of the HERG K + channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656

Lidoflazine is a high affinity blocker of the HERG K +channel

Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine

Inhibition of HERG Potassium Channel Current by the Class 1a Antiarrhythmic Agent Disopyramide

Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene—without QT interval prolongation

Characterisation of recombinant HERG K + channel blockade by the Class Ia antiarrhythmic drug procainamide

High affinity HERG K super(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656

Suchergebnisse filtern